# Minimal Residual Disease in Peripheral T-cell Lymphoma

> **NCT03297697** · — · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 44 (actual)

## Conditions studied

- Peripheral T Cell Lymphoma

## Interventions

- **PROCEDURE:** Tumor biopsy
- **PROCEDURE:** Peripheral blood draw
- **PROCEDURE:** Lymphotrack TCR clonality assay

## Key facts

- **NCT ID:** NCT03297697
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-31
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03297697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03297697, "Minimal Residual Disease in Peripheral T-cell Lymphoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03297697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*